| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |